FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nicotine 7mg/24hours transdermal patches (Ennogen Healthcare Ltd) 7 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (Waymade Healthcare Plc) 9 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 25micrograms/24hours transdermal patches (Ennogen Healthcare Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patches (Ennogen Healthcare Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patches (Ennogen Healthcare Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patches (Ennogen Healthcare Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 25micrograms/24hours transdermal patches (Ennogen Healthcare Ltd) 8 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patches (Ennogen Healthcare Ltd) 28 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patches (Ennogen Healthcare Ltd) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patches (Ennogen Healthcare Ltd) 28 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Waymade Healthcare Plc) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 12micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 25micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 50micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 75micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 100micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 12micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 25micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 50micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 75micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 100micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (DE Pharmaceuticals) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patches (DE Pharmaceuticals) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patches (DE Pharmaceuticals) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patches (DE Pharmaceuticals) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour transdermal patches (DE Pharmaceuticals) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (DE Pharmaceuticals) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (DE Pharmaceuticals) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (DE Pharmaceuticals) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (DE Pharmaceuticals) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches (DE Pharmaceuticals) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (DE Pharmaceuticals) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 100 patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 75 patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 100 patches (Waymade Healthcare Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 75 patches (Waymade Healthcare Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Waymade Healthcare Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 13.3mg/24hours transdermal patches (A A H Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 13.3mg/24hours transdermal patches (A A H Pharmaceuticals Ltd) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 7mg/24hours transdermal patches (The Boots Company Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 14mg/24hours transdermal patches (The Boots Company Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 21mg/24hours transdermal patches (The Boots Company Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist Translucent 10mg/16hours patches (The Boots Company Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist Translucent 15mg/16hours patches (The Boots Company Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist Translucent 25mg/16hours patches (The Boots Company Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 7mg/24hours transdermal patches (The Boots Company Plc) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 14mg/24hours transdermal patches (The Boots Company Plc) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 21mg/24hours transdermal patches (The Boots Company Plc) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist Translucent 10mg/16hours patches (The Boots Company Plc) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist Translucent 15mg/16hours patches (The Boots Company Plc) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist Translucent 25mg/16hours patches (The Boots Company Plc) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 25micrograms/24hours transdermal patches (J M McGill Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patches (J M McGill Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patches (J M McGill Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patches (J M McGill Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 7mg/24hours transdermal patches (J M McGill Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 25micrograms/24hours transdermal patches (J M McGill Ltd) 8 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patches (J M McGill Ltd) 28 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patches (J M McGill Ltd) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patches (J M McGill Ltd) 28 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 7mg/24hours transdermal patches (J M McGill Ltd) 7 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 20micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 10micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 5micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 20micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 10micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 5micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 15micrograms/hour transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 15micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 15micrograms/hour transdermal patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 15micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 100micrograms/24hours transdermal patches (Colorama Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours transdermal patches (Colorama Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 75micrograms/24hours transdermal patches (Colorama Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patches (Colorama Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patches (Colorama Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 100micrograms/24hours transdermal patches (Colorama Pharmaceuticals Ltd) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours transdermal patches (Colorama Pharmaceuticals Ltd) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 75micrograms/24hours transdermal patches (Colorama Pharmaceuticals Ltd) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patches (Colorama Pharmaceuticals Ltd) 28 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patches (Colorama Pharmaceuticals Ltd) 28 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (Alliance Healthcare (Distribution) Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 17 of 21 Next End

This concept is not in any reference sets

Back to Start